Humana, Inc. (Venture Capital) invested in Accolade, Inc.

Nov 08, 2019
Background Information
Humana Ventures' strategy is to leverage the core assets of Humana, Inc. to capitalize on the convergence of the Internet with the healthcare industry. The firm invests in innovative health care companies, focusing especially on new technology. They look for high quality healthcare solutions that improve health using digital technology and clinical knowledge. Humana Ventures focuses on partnership opportunities in healthcare services, connectivity and medical informatics. Computer applications that turn data into clinical knowledge are high priorities.Humana Ventures invests in companies at all stages of development at terms typical in venture financings. They will invest alone but prefer to co-invest with professional venture firms and other strategic partners. Investments range from $1 million to $10 million per transaction, but the firm prefers investments of at least $5 million. Humana Ventures also prefers to have an equity position between 10% and 35%. They serve as an active strategic partner and prefer board representation on their portfolio companies' boards of directors.
Accolade, Inc. provides healthcare assistance services. It helps individuals and their families get the right care by giving them access to health benefits or healthcare information. The firm specializes in healthcare process improvement, healthcare savings, and employee engagement. The company was founded by Thomas K. Spann and J. Michael Cline in 2007 and is headquartered in Plymouth Meeting, PA.